These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11231719)

  • 1. Reduction of lipoprotein(a) in postmenopausal women.
    Dalessandri KM
    Arch Intern Med; 2001 Mar; 161(5):772-3. PubMed ID: 11231719
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple Methods for Reduction of Lipoprotein(a).
    Dalessandri KM
    Atherosclerosis; 2002 Aug; 163(2):409-10. PubMed ID: 12052489
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy.
    Estellés A; Cano A; Falcó C; España F; Gilabert J; Grancha S; Aznar J
    Thromb Haemost; 1999 Jan; 81(1):104-10. PubMed ID: 10348700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) and postmenopausal oestrogen.
    Farish E; Rolton HA; Barnes JF; Fletcher CD; Walsh DJ; Spowart KJ; Hart DM
    Acta Endocrinol (Copenh); 1993 Sep; 129(3):225-8. PubMed ID: 8212987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.
    Anagnostis P; Karras S; Lambrinoudaki I; Stevenson JC; Goulis DG
    Int J Clin Pract; 2016 Dec; 70(12):967-977. PubMed ID: 28032426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
    Espeland MA; Marcovina SM; Miller V; Wood PD; Wasilauskas C; Sherwin R; Schrott H; Bush TL
    Circulation; 1998 Mar; 97(10):979-86. PubMed ID: 9529266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?
    Bukowska H; Stanosz S; Zochowska E; Millo B; Sieja K; Chełstowski K; Naruszewicz M
    Metabolism; 2005 Jan; 54(1):72-8. PubMed ID: 15562383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) risk in women and efficacy of ascorbate.
    Bostom AG
    JAMA; 1994 Oct; 272(15):1169. PubMed ID: 7933344
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
    JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone-replacement therapy, plasma lipoprotein[a], and risk for coronary heart disease.
    Gotto AM
    J Lab Clin Med; 1994 Jun; 123(6):800-3. PubMed ID: 8201254
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein(a): medical treatment options for an elusive molecule.
    Parhofer KG
    Curr Pharm Des; 2011; 17(9):871-6. PubMed ID: 21476974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study.
    Haines C; Chung T; Chang A; Masarei J; Tomlinson B; Wong E
    Arch Intern Med; 1996 Apr; 156(8):866-72. PubMed ID: 8774205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipids, lipoprotein Lp(a), apolipoproteins, and hemostatic risk factors distributions in postmenopausal women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Reiner Z; Zrinski R
    Acta Med Croatica; 1999; 53(2):61-6. PubMed ID: 10705622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hypercholesterolaemia in postmenopausal women.
    Davidson MH; Maki KC; Karp SK; Ingram KA
    Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy.
    Evola G; Novo G; Amoroso G; Guttilla D; Lo Coco L; Guagliardo M; Lupo A; Averna MR; Giambanco V; Miller V; Novo S
    Int Angiol; 2010 Aug; 29(4):355-61. PubMed ID: 20671654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.
    Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT
    Atherosclerosis; 1996 Jan; 119(2):215-22. PubMed ID: 8808498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women.
    Wen Y; Doyle MC; Norris LA; Sinnott MM; Cooke T; Harrison RF; Feely J
    Br J Clin Pharmacol; 1999 Mar; 47(3):315-21. PubMed ID: 10218915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.